<DOC>
	<DOCNO>NCT02766933</DOCNO>
	<brief_summary>The natural history response therapy chronic hepatitis B infection West Africa currently poorly understood . In study , employee Cameroon Baptist Convention Health Board ( CBCHB ) spouses find hepatitis B positive screening offer enrollment . Disease monitor treatment provide follow current WHO guideline . Clinical data prospectively record 5 year , bio-specimens frozen future analysis .</brief_summary>
	<brief_title>Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study</brief_title>
	<detailed_description>Chronic hepatitis B ( CHB ) common Cameroon , hepatitis B-related hepatocellular carcinoma lead cause cancer death throughout West Central Africa . Little known natural history CHB sub-Saharan Africa long term response antiviral therapy . The study hypothesis determine prospective follow-up population-based cohort . Aims , purpose , objective : 1 . To determine characteristic population asymptomatic Cameroonian adult work Cameroon Baptist Convention Health Board ( CBCHB ) chronic hepatitis B infection . 2 . To determine phase infection Hepatitis B carrier fall . 3 . To determine incidence risk factor cirrhosis , decompensated cirrhosis , hepatocellular carcinoma cohort time . 4 . To offer treatment accord standardize protocol , determine outcome treatment . 5 . To archive serum sample patient potential future study specific marker associate hepatitis B liver disease outcomes . Methods : Adult employee Cameroon Baptist Convention Health Board ( CBCHB ) spouses know positive hepatitis B surface antigen ( HBsAg+ ) offer enrollment cohort study CHB . Following enrollment , stage disease determine use clinical , laboratory image study . Patients follow regular interval 5 year . Antiviral therapy offer patient qualify accord current World Health Organization guideline . Significance : This protocol prospectively determine scope CHB-related illness initially asymptomatic , population-based cohort outcome current WHO treatment guideline African cohort .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>Age least 18yrs . CBCHB employee spouse employee . Able provide write informed consent . Willing comply followup visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>tenofovir</keyword>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>cirrhosis</keyword>
</DOC>